感谢关注全国卫生产业企业管理协会卫生健康适宜技术分会官网 登录 / 注册

核医学科

全国卫生产业企业管理协会健康服务适宜技术分会专家智库: 医技科专家 > 核医学科
全国卫生产业企业管理协会健康服务适宜技术分会专家智库
特邀专家 张晓丽
添加人:蒋灵灵     添加时间:2020年12月22日     阅读: 1986 次     来源:健康服务适宜技术分会


      张晓丽,女,主任医师/教授,博士生导师,美国UCLA 博士后。现任安贞医院核医学科主任。中华医学会核医学分会全国常委,对外交流+神经学组组长。国内最早开展心肌代谢显像评估存活心肌,在国际核心脏病领域有一定学术地位。个人并带领团队获SNMMI青年科学家奖3次(中国核医学医生首次获奖),入选SNMMI highlights 5次和中美核医学学会最佳优秀论文奖。署名论文和国际会议150余篇,其中SCI近40篇, IF>200,他引近2000次,参编中英文专著近20部。获国之名医优秀风范奖,中华医学会核医学分会特别贡献奖和北京市“三八”红旗手。主审主译《核心脏病学临床应用》。

    专业擅长: 1.18F-FDG PET心肌代谢显像评估存活心肌的临床和基础的系列研究

2.核心脏病学对冠心病精准诊断、个体化治疗决策制定和危险分层

科技成果: 1.Mou T, Tian J, Tian Y, Yun M, Li J, Dong W, Lu X, Zhu Z, Mi H, Zhang X#, Li X, Automated synthesis and preliminary evaluation of ­[18F]FDPA for cardiac inflammation imaging in rats after myocardial infarction. Sci Rep; 2020. (IF: 3.998) DOI:10.1038/s41598-020-75705-2 (被引用: 0次)
2.Tian Y, Zhao M#, Li W, Zhu Z, Mi H, Li X, Zhang X#(并列通讯), Left ventricular mechanical dyssynchrony analzyed by Tc-99m sestamibi SPECT and F-18 FDG PET in patients with ischemic cardiomyopathy and the prognostic value. Int J Cardiovasc Imaging; 2020, 36(10):2063-2071. (IF: 1.969) DOI:10.1007/s10554-020-01904-7 (被引用: 0次)
3.Lu X , Zhao M, Tian C, Wei H, Gao M, Yang X, Zhang X#, Li X, Prognostic value of ventricular mechanical dyssynchrony in patients with left ventricular aneurysm: A comparative study of medical and surgical treatment. J Nucl Cardiol; 2020. (IF: 3.366) (被引用: 0次)
4.Dong W, Li Y, Zhu J, Xia J, He L, Yun M, Jiao J, Zhu G, Hacker M, Wei Y, Zhang X#, Li X, Detection of aortic prosthetic graft infection with 18F-FDG PET/CT imaging, concordance with consensus MAGIC graft infection criteria. J Nucl Cardiol; 2020. DOI:10.1007/s12350-020-02227-9 (IF: 3.366) (被引用: 0次)
5.Yun M, Nie B(共同一作), Wen W, Zhu Z, Liu H, Nie S, Lanzenberger R, Wei Y, Hacker M, Shan B, Schelbert HR, Li X, Zhang X#, Assessment of cerebral glucose metabolism in patients with heart failure by 18F-FDG PET/CT imaging, J Nucl Cardiol; 2020. DOI:10.1007/s12350-020-02258-2 (IF: 3.366) (被引用: 0次)
6.Meng J*, Zhao H, Liu Y, Chen D, Hacker M, Wei Y, Li X*(共同一作), Zhang X#, Kreissl M. Assessment of cardiac tumors by 18F-FDG PET/CT imaging: Histological correlation and clinical outcomes. J Nucl Cardiol; 2020. DOI: 10.1007/s12350-019-02022-1 (IF: 3.366) (被引用: 0次) 

7.Li X, Yu W, Wollenweber T, Lu X, Wei Y, Beitzke D, Wadsak W, Kropf S, Wester HJ, Haug AR, Zhang X# and Hacker M#(并列通讯). [(68)Ga]Pentixafor PET/MR imaging of chemokine receptor 4 expression in the human carotid artery. Eur J Nucl Med Mol Imaging;2019,46(8):1616-1625. (IF: 7.081). (被引用: 5次)
8.Li J, Yang X, Tian Y, Wei H, Hacker M, Li X# and Zhang X#(并列通讯). Complete revascularization determined by myocardial perfusion imaging could improve the outcomes of patients with stable coronary artery disease, compared with incomplete revascularization and no revascularization. J Nucl Cardiol;2019,26(3):944-953. (IF: 3.366). (被引用:2次) 
9.Wang W, Li X, Tian C, Zhao S, Hacker M and Zhang X#. Cardiac death in patients with left ventricular aneurysm, remodeling and myocardial viability by gated 99mTc-MIBI SPECT and gated 18F-FDG PET. Int J Cardiovasc Imaging;2018,34(3):485-493. (IF:1.969) (被引用: 2次)
10.Lu X, He P#, Luo Z, Zhang X#(并列通讯). Gefitinib enhances radiotherapeutic effects of 131I-hEGF targeted to EGFR by increasing tumor uptake of hEGF in tumor xenografts. Nucl Med Biol;2017,48(63-68). (IF:2.396) (被引用: 0次)
11.Li J, Schindler TH, Qiao S, Wei H, Tian Y, Wang W, Zhang X#, Yang X#(并列通讯) and Liu X . Impact of incomplete revascularization of coronary artery disease on long-term cardiac outcomes. Retrospective comparison of angiographic and myocardial perfusion imaging criteria for completeness. J Nucl Cardiol;2016,23(3):546-555. (IF: 3.366)) (被引用:4次)
12.Zhang X*, Yang Y, Wei H, Tian Y, Shi H, Wang Y#, Li S#(并列通讯), He Z, Li Y, Liu X. State and Recent Progress of Nuclear Cardiology in China. Current Cardiovascular Imaging Report;2015,8(5):17-27.(Springer系列) (被引用: 0次)

13.Wei H, Tian C, Schindler TH, Qiu M, Lu M#, Shen R, Tian Y, Zhao SH, Zhang X#(并列通讯). The impacts of severe perfusion defects, akinetic/dyskinetic segments, and viable myocardium on the accuracy of volumes and LVEF measured by gated 99mTc-MIBI SPECT and gated 18F-FDG PET in patients with left ventricular aneurysm: cardiac magnetic resonance imaging as the reference. J Nucl Cardiol;2014,21(6):1230-1244. (IF: 3.366)) (被引用: 10次) 
14.Zhang X*, Schindler T, Prior J, Sayre J, Dahlbom M, Huang S and Schelbert H#. Blood flow, flow reserve, and glucose utilization in viable and nonviable myocardium in patients with ischemic cardiomyopathy. Eur J Nucl Med Mol Imaging;2013,40(4):532-541. (IF: 7.081) (被引用: 9次)
15.Zhang X*#, Liu X, Hu S, Schindler T, Tian Y, He Z, Gao R, Wu Q, Wei H, Sayre J and Schelbert H. Long-term survival of patients with viable and nonviable aneurysms assessed by 99mTc-MIBI SPECT and 18F-FDG PET: a comparative study of medical and surgical treatment. J Nucl Med;2008,49(8):1288-1298. (IF:7.887) (被引用:31次)
16.Schindler T*, Zhang X*(并列第一), Prior J, Cadenas J, Dahlbom M, Sayre J and Schelbert H#. Assessment of intra- and interobserver reproducibility of rest and cold pressor test-stimulated myocardial blood flow with (13)N-ammonia and PET. Eur J Nucl Med Mol Imaging;2007,34(8):1178-1188. (IF: 7.081) (被引用:79次)
17.Zhang X*, Liu X#, He ZX, Shi R, Yang M, Gao R, Chen J, Yang Y and Fang W. Long-term prognostic value of exercise 99mTc-MIBI SPET myocardial perfusion imaging in patients after percutaneous coronary intervention. Eur J Nucl Med Mol Imaging;2004,31(5):655-662. (IF: 7.081) (被引用:53次)

18.Zhang X*, Liu X#, Wu Q, Shi R, Gao R, Liu Y, Hu S, Tian Y, Guo S and Fang W. Clinical outcome of patients with previous myocardial infarction and left ventricular dysfunction assessed with myocardial 99mTc-MIBI SPECT and 18F-FDG PET. J Nucl Med;2001,42(8):1166-1173. (IF:7.887) (被引用:159次)
19.Zhang X*, Liu X, Shi R, Wu Q, Gao R, Liu Y, Hu S, Guo S, Xie F and Li Y. Evaluation of the clinical value of combination of 99mTc-MIBI myocardial SPECT and 18F-FDG PET in assessing myocardial viability. Radiat Med;1999,17(3):205-210. (被引用:36次) 

上一位专家: 刘学公 下一位专家: 于 璟